The Gilead Australia Fellowship is offering up to $250,000 to fund research projects in HIV, viral hepatitis or haematological oncology.
Research proposals are invited that explore and address the following issues and themes:
- Developing and/or evaluating novel ways to prevent new HIV and/or chronic viral hepatitis infections
- Improving community and primary care awareness, interest and uptake of screening to identify undiagnosed people with HIV and/or chronic viral hepatitis in high prevalence populations
- Reducing late diagnosis
- Improving access, uptake and adherence to medication, with emphasis on marginalised groups such as Indigenous communities, drug users and immigrants
- Developing strategies to support the management of long-term complications
- Identifying the reasons for and strategies to reduce patients being lost to follow-up
- Improving adherence to long-term medication through innovative programs
- Improving the care of patients with haematological malignancies
Who can apply?
Applications are encouraged from researchers at Australian hospitals, clinics, universities, research institutes and professional organisations, including:
- Clinical and academic staff
- Young investigators
- Other healthcare providers / researchers
Applications will close on 31 August 2016. Projects must be completed by the end of 2017.
All applications must be submitted online via the Gilead Australa Fellowship website www.gileadfellowship.com.au